AzurRx BioPharma, Inc. Gains 34.55%
Thu, Jan 21, 2021 at 05:30 PM
AzurRx BioPharma, Inc. (AZRX:NASDAQ) soared at $1.24, representing a gain of 34.5%. On Wed 20 Jan 21, AZRX:NASDAQ hit a New 2-Week Intraday High of $0.95. The stock got featured on our News Catalysts scanner on Thu 21 Jan 21 at 10:27 AM in the 'BIOTECH' category. From Wed 06 Jan 21, the stock recorded 55.56% Up Days and 20.00% Green Days
The stock spiked on Tue 12 Jan 21 at $1.24 with a volume of 22M+, and its share price has been moving sideways in recent weeks.
About AzurRx BioPharma, Inc. (AZRX:NASDAQ)
AzurRx BioPharma Inc through its subsidiary is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its products under development includes MS1819 and AZ1101.
Top 10 Gainers:
- BBIG (BBIG:NASDAQ), 196.1%
- Qutoutiao Inc. (QTT:NASDAQ), 61.34%
- ADTX (ADTX:NASDAQ), 45.59%
- Ideal Power Inc. (IPWR:NASDAQ), 44.57%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 40.66%
- Celsion Corporation (CLSN:NASDAQ), 36.47%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 35.63%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 34.55%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 32%
- Castor Maritime Inc. (CTRM:NASDAQ), 30.77%